Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 17, 2023 08:00 ET | Source: Sensus Healthcare, Inc.

Sensus Healthcare's SRT Treatment Shows Promise in Treating Cutaneous Mast Cell Tumors Among Pet Patients

BOCA RATON, Fla, May 17, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare Inc. (Nasdaq:SRTS), the leading manufacturer of advanced medical devices for non-surgical skin cancer and keloid scar treatment,...
October 22, 2020 08:00 ET | Source: Sensus Healthcare, Inc.

Sensus Healthcare Announces Publication of Study Showing Use of Superficial Radiation Therapy Post-Keloidectomy Prevents Keloid Recurrence

Keloid recurrence rate of 10.4% at 12 months for patients treated with SRT following keloidectomy compares with more than 80% with surgical excision aloneRetrospective study published in Journal of...
August 05, 2020 08:30 ET | Source: Sensus Healthcare, Inc.

American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units

Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systems BOCA RATON, Fla, Aug. 05, 2020 (GLOBE NEWSWIRE) -- ...
July 28, 2020 08:30 ET | Source: Sensus Healthcare, Inc.

Sensus Healthcare Names Hoi-Bun “Benson” Suen Vice President of International Sales, Ships SRT-100™ to China

BOCA RATON, Fla. , July 28, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
July 14, 2020 08:00 ET | Source: Sensus Healthcare, Inc.

Evidence-Based Guidelines Issued by ASTRO Support Sensus Healthcare’s SRT Technology as the First-Line Alternative to Surgery for Treating Non-Melanoma Skin Cancer

Influential professional organization recommends radiotherapy as the primary non-surgical alternative for patients with basal cell or cutaneous squamous cell carcinomas BOCA RATON, Fla, July 14,...